PROGRAMME - mri.tum.de

Chairman Hans-Henning EcksteinMunich, Germany

Venue Klinikum rechts der Isar Munich, Germany

Congress organisationCongO GmbH Ruffinistraße 1680637 Munich, Germany

06–08 December | Klinikum rechts der Isar | Munich | Germany

PROGRAMMEwww.mac-conference.com

2 3

CO-CHAIRMEN FROM MUNICH, GERMANY:

SCIENTIFIC ORGANISER

Dear friends of the MUNICH VASCULAR CONFERENCE,

It is our pleasure to welcome you to the 8th MUNICH VASCULAR CONFERENCE (MAC). The 8th MAC continues to be a platform for mutual exchange between vascular clinicians from all vascular medical specialties and colleagues from translational and basic research.

The 8th MAC addresses aortic, carotid, venous, and peripheral arterial diseases again. We will present the latest advances in clinical and translational vascular research, including the newest open and endovascular technologies, biological mechanisms of atherosclerosis and the latest imaging modalities.

Do not miss the latest insights into the world of academic vascular research, represented by our world-class faculty. The 8th MAC provides the latest news and cutting-edge approaches in the management of acute and chronic arterial and venous diseases.

Sincerely yours

WELCOME

Prof. Hans-Henning Eckstein Chairman

Holger PoppertHead of the Department for Neurology, Helios Klinikum Wiesbaden, Germany and Lecturer at the Technical University of Munich, Germany

Michael GeeHead of the Mechanics and High Performance Computing Group, Technical University of Munich, Germany

Wolfgang WallHead of the Institute for Computational Mechanics, Technical University of Munich, Germany

Lars MaegdefesselHead of the Experimental Vascular Medicine Group, Department for Vascular and Endovascular Surgery, Technical University of Munich, Germany

Claus ZimmerHead of the Department for Neuroradiology, Universitätsklinikum rechts der Isar, Technical University of Munich, Germany

Hans-Henning EcksteinHead of the Department for Vascular and Endovascular SurgeryUniversitätsklinikum rechts der Isar, Technical University of Munich, GermanyIsmaninger Strasse 22 81675 Munich, Germany

4 5

KMichael Kallmayer, Vascular Surgery, Munich, GermanyPiotr Kasprzak, Vascular Surgery, Regensburg, GermanyAthanasios Katsargyris, Vascular Surgeon, Nuremberg, GermanyThorsten Kessler, Vascular Research, Munich, GermanyMarkus Kleemann, Vascular Surgery, Lübeck, GermanyChristoph Knappich, Vascular Surgery, Munich, GermanyRalf Kolvenbach, Vascular Surgery, Düsseldorf, GermanyIgor Končar, Vascular Surgery, Belgrade, SerbiaKornelia Kreiser, Neuroradiology, Munich, GermanyMario Kuhnert, Vascular Surgery, Birkenwerder, Germany

LChristos Liapis, Vascular Surgery, Athens, Greece

Thomas Liebig, Neuroradiology, Munich, GermanyJes Sanddal Lindholt, Vascular Surgery, Odense, DenmarkLars Lönn, Radiology, Copenhagen, Denmark

MSumaira Macdonald, Radiology, Sunnyvale, USAArmando Mansilha, Vascular Surgery, Porto, PortugalKlaus Mathias, Radiology, Hamburg, GermanyBijan Modarai, Vascular Surgeon, London, UK

NJonathan Nadjiri, Radiology, Munich, GermanyAchim Neufang, Vascular Surgery, Wiesbaden, GermanyJan Nilsson, Vascular Research, Malmö, Sweden

OAlexander Oberhuber, Vascular Surgery, Münster, GermanyStefan Ockert, Vascular Surgery, Lucerne, Switzerland

PKosmas Paraskevas, Vascular Surgeon, London, UKJaroslav Pelisek, Vascular Research, Munich, GermanyKarin Pfister, Vascular Surgery, Regensburg, GermanyThomas Pröbstle, Dermatology, Mannheim, Germany

RBarbara Rantner, Vascular Surgery, Innsbruck, AustriaMichael Rasper, Radiology, Munich, GermanyChristian Reeps, Vascular Surgery, Dresden, GermanyTilman Reiff, Neurology, Heidelberg, Germany

AStéphane Avril, Biomedical Engineering, St. Etienne, France

BChristian Baars, Journalist, Hamburg, GermanyMarc Bailey, Vascular Surgery, Leeds, UKAndrew Baker, Vascular Biology, Edinburgh, UKMohammad E. Barbati,Vascular Surgery,Aachen, GermanyEva Bartels, Neurology, Munich, GermanyJan Beyer-Westendorf, Angiology, Dresden, GermanyColin Bicknell, Vascular Surgery, London, UKGabor Biro, Vascular Surgery, Munich, GermanyDittmar Böckler, Vascular Surgery, Heidelberg, GermanyLeo Bonati, Neurology, Basle, Switzerland

Marianne Brodmann, Angiology, Graz, AustriaRichard Bulbulia, Vascular Surgery, Oxford, UKAlbert Busch, Vascular Surgery, Munich, Germany

CTina Cohnert, Vascular Surgery, Graz, AustriaMartin Czerny, Cardiovascular Surgery, Freiburg, Germany

DGert J. de Borst, Vascular Surgery, Utrecht, The NetherlandsJean-Paul de Vries, Vascular Surgery, Groningen, The NetherlandsSebastian Debus, Vascular Surgery, Hamburg, GermanyMartin Dichgans, Neurology, Munich, Germany

EChristine Espinola-Klein, Angiology, Mainz, Germany

FHans Förstl, Psychiatry, Munich, GermanyRachael Forsythe, Vascular Surgery, Edinburgh, UK

GThomas Gasser, Biomedical Engineering, Stockholm, SwedenGeorge Geroulakos, Vascular Surgery, Athens, GreeceAthanasios Giannoukas, Vascular Surgery, Larissa, GreeceJens Göttler, Neuroradiology, Munich, Germany

HAlison Halliday, Vascular Surgery, Oxford, UKTobias Hirsch, Angiology, Halle, GermanyRebecka Hultgren, Vascular Research, Stockholm, Sweden

JHouman Jalaie, Vascular Surgery, Aachen, Germany

INVITED FACULTYINVITED FACULTY

6 7

ABSTRACT SUBMITTERS AND WORKSHOP CONVENORSINVITED FACULTY

RBenedikt Reutersberg, Vascular Surgery, Munich, GermanyCelia Riga, Vascular Surgery, London, UKPeter Ringleb, Neurology, Heidelberg, GermanySteven Rogers, Vascular Research, Manchester, UKJoy Roy, Vascular Research, Stockholm, Sweden

SMarc Schermerhorn, Vascular Surgery, Boston, USAClaus-Georg Schmedt, Vascular Surgery, Schwäbisch Hall, GermanyThomas Schmitz-Rixen, Vascular Surgery, Frankfurt, GermanyJulian Scott, Vascular Surgery, Leeds, UKJudith Sluimer, Vascular Research, Maastricht, The Netherlands

Michael Spannagl, Haemostaseology, Munich, GermanyDavid Spence, Neurology, London, Canada Thomas Stadlbauer, Angiology, Munich, GermanyTobias Steinke, Vascular Surgery, Düsseldorf, GermanyKerstin Stoklasa, Vascular Surgery, Munich, Germany

TGunnar Tepe, Radiology, Rosenheim, GermanyMatthias Trenner, Vascular Surgery, Munich, Germany

VJos van den Berg, Radiology, Lugano, SwitzerlandEric Verhoeven, Vascular Surgery, Nuremberg, GermanyPirkka Vikatmaa, Vascular Surgery, Helsinki, Finland

WAnders Wanhainen, Vascular Surgery, Uppsala, SwedenRolf Weidenhagen, Vascular Surgery, Munich, GermanyHeiko Wendorff, Vascular Surgery, Munich, GermanyUta Werthern, Vascular Surgery, Munich, GermanyMike Wyatt, Vascular Surgery, Newcastle, UK

ZClark Zeebregts, Vascular Surgery, Groningen, The NetherlandsThomas Zeller, Angiology, Bad Krozingen, GermanyAlexander Zimmermann, Vascular Surgery, Munich, Germany

Makhmud Akhmad Kyiv, UkraineRita Augusto, Vila Nova de Gaia, PortugalJacinta Campos, Vila Nova de Gaia, PortugalMikhail Chernyavskiy, Novosibirsk, RussiaJasamine Coles-Black, Melbourne, AustraliaShelby Cooper, Cooperstown, United StatesSabine Dallmann-Sieber, Munich, GermanyEvelien de Vries, Utrecht, The NetherlandsDmitry Dombrovsky Tscherniwtzi, UkraineWolf Eilenberg, Vienna, AustriaAhmed Eleshra Hamburg, GermanyTheresia Faber Hamburg, GermanyLeonie Fassaert, Utrecht, The NetherlandsLuís Gamas, Porto, PortugalAlexander Gombert, Aachen, GermanyAstrid Hoving, Utrecht, The NetherlandsMohamed Ismail Cairo, Egypt

Heli Järve, Tartu, EstoniaAdel Hussein Kamhawy, Tanta, EgyptMark Kaschwich, Lübeck, GermanyArnaud Kerzmann, Liège, BelgiumAkshitha Kesharaju, Bristol, United KingdomIhor Kobza, Lviv, UkrainePeter Konstantiniuk, Graz, AustriaMartin Lawaetz, Copenhagen, DenmarkYuriy Levchak, Uzhhorod, UkraineShengliang Liu, Munich, GermanyMartina Lopatta, Munich, GermanyBianca Marinelli Teixeira, Berlin, GermanyAndrea Masset, Munich, GermanyArmelle Meershoek, Utrecht, The NetherlandsDylan Morris, Melbourne, AustraliaAhmad Naga, Alexandria, EgyptMohamed Ayman Nagib, Cairo, Egypt

Sohiel Nagib, Alexandria, EgyptAndrij Nykonenko, UkraineValentina Paloschi, Munich, GermanyViktor Pavlychenko UkrainePedro Pinto Sousa, Vila Nova de Gaia, PortugalVanessa Pourier, Utrecht, The NetherlandsMarjolijn Rots, Utrecht, The NetherlandsChristoph Schäffer, Munich, GermanyJoachim Schmidt, Dresden, GermanyAli Shahriari, Boca Raton, United StatesKonstantinos Spanos, Volos, GreeceReshaabi Srinanthalogen, Viborg, DenmarkMangesh Tarte, IndiaMarkus Wagenhäuser, Düsseldorf, GermanyHanna Winter, Munich, Germany

8 9

WELCOME 2SCIENTIFIC ORGANISER 3INVITED FACULTY 4ABSTRACT SUBMITTERS AND WORKSHOP CONVENORS 7GENERAL INFORMATION 9PROGRAMME | WEDNESDAY, 05 DECEMBER 2018 13

Spezialkurs Interventionsradiologie zum Erwerb der Fachkunde (§18a RöV) 13OVERVIEW SCIENTIFIC SESSIONS 14PROGRAMME | THURSDAY, 06 DECEMBER 2018 18

Carotid Artery Disease (CAD) Sessions 1–4 18Aortic (AOR) Sessions 1–3 22Special Session on Radiation Protection 24Peripheral Arterial Disease (PAD) Sessions 1–2 25

PROGRAMME | FRIDAY, 07 DECEMBER 2018 28Carotid (CAD) Sessions 5–6 28Aortic (AOR) Sessions 4–7 29Peripheral Arterial Disease (PAD) Sessions 3–6 33Special Session on Vascular Team Training 36

PROGRAMME | SATURDAY, 08 DECEMBER 2018 38Venous (VEN) Sessions 1–4 38

MINI-SYMPOSIUM | THURSDAY, 06 DECEMBER 2018 42MINI-SYMPOSIUM 1 42

MINI-SYMPOSIA | FRIDAY, 07 DECEMBER 2018 43MINI-SYMPOSIUM 2 43MINI-SYMPOSIUM 3 43

SPONSORED / UNSPONSORED WORKSHOPS THURSDAY 46SPONSORED / UNSPONSORED WORKSHOPS FRIDAY 50KEYNOTE/ SPECIAL LECTURES 52

DATE AND VENUE06-08 December 2018Klinikum rechts der Isar | Munich | Germany

Main entrance:Klinikum rechts der IsarIsmaninger Strasse 2281675 Munich, Germany

SOCIAL DINNERJoin us for dinner, drinks, and music at the Nightclub Bayerischer Hof, MunichDate: Thursday, 06 December 2018Administration fee: EUR 50.00 (limited seats only)(Registration for the social dinner is only possible in conjunction with a conference registration)

GENERAL INFORMATIONTABLE OF CONTENT

OFFICIAL LANGUAGEEnglish

FREE WIFI: Network: BayernWLAN

Entrance plenary rooms:Klinikum rechts der Isar Einsteinstrasse 581675 Munich, Germany

10 11

REGISTRATION HOURSWednesday 05 December 14.00-18.00Thursday 06 December 08.00-18.00Friday 07 December 08.00-18.00Saturday 08 December 08.30-12.00

REGISTRATION FEESFull Registration (06-08 December)• Physicians / Industry representatives: EUR 390.00• Fellows, Nurses, and Medical Technical Assistants (verification required 1): EUR 150.00• Students free of charge (verification required 2): EUR 0.00

Day Registration (06, 07, or 08 December)• Physicians / Industry representatives: EUR 180.00• Fellows, Nurses, and Medical Technical Assistants (verification required 1): EUR 75.00• Students free of charge (verification required 2): EUR 0.00

1) The reduced registration fee is only available to participants who are currently employed as fellows (assistant physicians), nurses, or medical technical assistants. Please provide proof of your current employment status. We accept ENGLISH or GERMAN verifications.2) The reduced registration fee is only available to students who have not concluded their first study yet and who are currently enrolled at the university.Please provide proof of your current university enrollment. We accept ENGLISH or GERMAN verifications.

WORKSHOPSWorkshop registrations are only possible in connection with a registration for the Munich Vascular Conference 2018. Food and beverages are included in the registration fee. Workshop: Wednesday, 05 December 2018Spezialkurs Interventionsradiologie zum Erwerb der Fachkunde – 1-day course on radiation safety – only for German participants.• MAC participants: EUR 180.00• Employees of the MRI: EUR 50.00

ACCREDITATIONBavarian Medical Association (BLAEK)The programme of the 8th Munich Vascular Conference, 06-08 December 2018, is accredited by the Bavarian Medical Association (BLAEK) for 15 hours of external CME credits. Each participant should claim only those hours of credit that have actually been spent in the educational activity.

European Accreditation Council for Continuing Medical Education (EACCME®)8th Munich Vascular Conference, Munich, Germany, 06 – 08 December 2018 has been accredited by the European Accre-ditation Council for Continuing Medical Education (EACCME®) for a maximum of 19 European CME credits (ECMEC®s).Each medical specialist should claim only those credits that he/she actually spent in the educational activity.

EthicalMedTechThe 8th Munich Vascular Conference 2018 starting on 06 December 2018 in Munich, Germany has been rated compliant with the MedTech Europe Code of Ethical Business Practice.

The 8th Munich Vascular Conference 2018 is under the auspice of:

GENERAL INFORMATIONGENERAL INFORMATION

German Society for Angiology

German Vascular Society (DGG)

European Society for Vascular Medicine

12 13

WED

NESDAYSpezialkurs Interventionsradiologie zum Erwerb der Fachkunde (§18a RöV)

Anwendung von Röntgenstrahlung bei fluoroskopischen Interventionen an einem Organsystem und Röntgendiagnostik eines Organsystems: Gefäßsystem (peripher/zentral)

Der angebotene Strahlenschutzkurs wird von der Bayerischen Landesärztekammer auf der Basis der Lehrinhalte anerkannt.

Datum: Mittwoch, 05.12.2018 (9.00-16.30)Veranstalter: Univ.-Prof. Dr. H.-H. EcksteinKursleitung/Dozenten: OA Dr. H. Wendorff

(Fachkunde Interventionsradiologie) ltd. OA PD Dr. A. Zimmermann (Fachkunde Interventionsradiologie) Dipl.-Phys. B. Renger (Strahlenphysiker des Instituts für Röntgendiagnostik) OA Dr. Ch. Maegerlein (Facharzt Radiologie, OA Neuroradiologie) OA Dr. T. Stadlbauer (Facharzt für Kardiologie)

Ort: OP Zentrum Nord beim Buchstaben „K“ im 3. OG, Klinik und Poliklinik für Vaskuläre und Endovaskuläre Chirurgie, Klinikum rechts der Isar der Technischen Universität München, Ismaningerstr. 22, 81675 München.

Gebühr: Externe Kollegen: EUR 180.00; interne Mitarbeiter des MRI: EUR 50.00 Mitarbeiter Gefäßchirurgie des MRI: kostenfrei

Voraussetzung: Approbation, Grundkurs und Spezialkurs Röntgendiagnostik (nicht älter als 5 Jahre)

Inhalt: • Physikalisch-technische Grundlagen der Interventionsradiologie (Geräte- und Detektortechnologie - Dosismessgrößen – apparative Einflussfaktoren auf die Dosis – Aufnahmeparameter: Bedeutung für Bildqualität und Strahlenexposition) • Medizinische Anwendungen der Interventionsradiologie (Dosiswerte bei häufigen Untersuchungen – Strahlenexposition des Patienten und des Personals – Maßnahmen zur Dosisreduktion bei Patienten und Personal – Spezielle Techniken und ihre Anforderungen im Anwendungsbereich Gefäßinterventionen. Praxisbezogene Übungen und Demonstrationen zu dosisreduzierenden Maßnahmen – Fallbeispiele zur Analyse von Fehlern)

Zielgruppe: Gefäßchirurgen/Gefäßmediziner, die interventionell tätig sind, zur Erlangung der Fachkunde.

Hinweise: Anmeldung erforderlich, TeilnahmebestätigungTeilnehmerzahl: Dieser Kurs ist auf 15 Teilnehmer begrenzt

CONGRESS SECRETARIATAlbert BuschMichael KallmayerChristoph KnappichEva KnipferBenedikt ReutersbergChristine RudolfMatthias TrennerHeiko WendorffAlexander Zimmermann

Department forVascular and Endovascular SurgeryKlinikum rechts der IsarTechnical University of MunichIsmaninger Strasse 2281675 Munich, GermanyPhone: +49 (0)89 41 40 2167Fax: +49 (0)89 41 40 48 61E-Mail: [email protected]

CONGRESS ORGANISATION

CongO GmbH Ruffinistraße 16 80637 Munich, Germany

Contact: Antonie JägerE-Mail: [email protected]: +49 89 / 23 75 74 – 65 Fax: +49 89 / 23 75 74 – 70www.cong-o.com

PROGRAMME | WEDNESDAY, 05 DECEMBER 2018GENERAL INFORMATION

http://www.cong-o.com

mailto:toniejaeger%40cong-o.de?subject=AL16%20Exhibitors

14 15

OVERVIEW SCIENTIFIC SESSIONSOVERVIEW SCIENTIFIC SESSIONS

PROGRAMME | FRIDAY, 07 DECEMBER 201808.30-10.05 CAD 5 | Lecture Hall C Carotid Artery Disease (CAD) – from genes to therapies 2810.05-10.30 COFFEE BREAK __________________________________________________________10.30-11.40 CAD 6 | Lecture Hall C

Carotid plaque burden and vulnerability – assessment and clinical impact 28

11.40-12.30 LUNCH BREAK __________________________________________________________

08.30-10.05 AOR 4 | Lecture Hall B The new AAA guidelines from the SVS, ESVS, Germany, and UK (NICE) 2910.05-10.30 COFFEE BREAK __________________________________________________________10.30-12.00 AOR 5 | Lecture Hall B Endoleak prevention and management in complex aortic aneurysms 3012.00-13.00 LUNCH BREAK __________________________________________________________

12.30-12.45 Special Lecture 3 | Lecture Hall C Sarcopenia and outcomes in vascular surgery 3013.00-14.20 AOR 6 | Lecture Hall B

Ascending aorta and aortic arch 3114.20-14.50 COFFEE BREAK __________________________________________________________14.50-16.40 AOR 7 | Lecture Hall B Thoracic/Thoraco-abdominal aneurysm and dissections 3216.40-17.00 COFFEE BREAK __________________________________________________________12.45-14.30 PAD 3 | Lecture Hall C

Challenges in PAD – long and calcified lesions, in-stent-restenosis, CLI, and wound healing 33

14.30-14.50 COFFEE BREAK __________________________________________________________14.50-15.50 PAD 4 | Lecture Hall C

Update on lipid-lowering therapy in carotid and peripheral atherosclerosis 34

15.50-16.40 PAD 5 | Lecture Hall C Update on periprocedural and long-term platelet inhibition and anticoagulation in PAD 34

16.40-17.00 COFFEE BREAK __________________________________________________________17.00-18.00 PAD 6 | Lecture Hall C

Short communications on Peripheral Arterial Disease 3517.00-18.05 Special Session 2 | Lecture Hall B Team training, simulation, and augmented reality in the hybrid OR 36

PROGRAMME | THURSDAY, 06 DECEMBER 201809.00-10.35 CAD 1 | Lecture Hall B

Clinical and imaging variables in asymptomatic carotid patients with an increased late stroke risk – a critical review of the ESVS/ESC guidelines 2017 18

10.35-11.00 COFFEE BREAK __________________________________________________________11.00-12.25 CAD 2 | Lecture Hall B

More news on carotid revascularization strategies and long-term outcomes in (a)symptomatic patients 19

12.30-12.50 Special Lecture 1 | Lecture Hall B Cognitive impairment and dementia in politicians 19

12.50-13.30 LUNCH BREAK __________________________________________________________

13.30-14.55 CAD 3 | Lecture Hall B Carotid Stenosis Trialist Collaboration (CSTC) session 20

15.00-15.25 Special Lecture 2 | Lecture Hall B Deadly superbugs from Pharma factories – an investigative report from the NDR Hamburg 20

15.25-15.40 COFFEE BREAK __________________________________________________________17.25-18.30 CAD 4 | Lecture Hall C Short communications on Carotid Artery Diseases 21

09.00-10.40 AOR 1 | Lecture Hall C Short communications on Aortic Diseases 2210.40-11.00 COFFEE BREAK __________________________________________________________11.00-12.30 AOR 2 | Lecture Hall C

Dismantling AAAs – novel insights into disease mechanisms and future therapies 23

12.30-13.30 LUNCH BREAK __________________________________________________________

13.30-15.00 AOR 3 | Lecture Hall C Biomechanical simulation of aortic aneurysms 2415.00-15.30 COFFEE BREAK __________________________________________________________15.30-17.00 Special Session 1 | Lecture Hall C Hot topics in radiation protection 2018 2415.40-17.05 PAD 1 | Lecture Hall B

Innovative imaging and below-the-knee treatment modalities 2517.05-17.25 COFFEE BREAK __________________________________________________________17.25-18.30 PAD 2 | Lecture Hall B Peripheral and mesenteric vascular emergencies 26

16 17

OVERVIEW SCIENTIFIC SESSIONS

PROGRAMME | SATURDAY, 08 DECEMBER 201809.00-10.00 VEN 1 | Lecture Hall B Short communications on Venous Diseases 38

10.00-11.05 VEN 2 | Lecture Hall B Acute and chronic deep vein thrombosis (DVT) – conservative and recanalizing strategies 38

17.00-17.30 COFFEE BREAK __________________________________________________________11.30-13.00 VEN 3 | Lecture Hall B New developments in lower leg varicose vein disease 39

17.00-17.30 COFFEE BREAK __________________________________________________________13.30-14.45 VEN 4 | Lecture Hall B

The 2015 ESVS guidelines on chronic venous diseases – a critical review 40

14:45 FAREWELL _______________________________________________________________

MINI-SYMPOSIUM | THURSDAY, 06 DECEMBER 201813.30-14.15 Mini-Symposium 1 | Conference Room 1 Advance Therapy Outcomes in fenestrated and branched EVAR (Industry Sponsored) 42

MINI-SYMPOSIA | FRIDAY, 07 DECEMBER 201812.30-13.30 Mini-Symposium 2 | Conference Room 1 The venous challenge – successful strategies to treat venous lesions (Industry Sponsored) 43

15.00-16.00 Mini-Symposium 3 | Conference Room 1 Acute Type A dissections: changing paradigms? (Industry Sponsored) 43

SPONSORED / UNSPONSORED WORKSHOPS THURSDAY 46

SPONSORED / UNSPONSORED WORKSHOPS FRIDAY 50

KEYNOTE / SPECIAL LECTURES 52

NOTES

18 19

PROGRAMME | THURSDAY, 06 DECEMBER 2018

11.00-12.25 CAD 2 | Lecture Hall B More news on carotid revascularization strategies and long-term outcomes in (a)symptomatic patients

Chair: Peter Ringleb, Kornelia Kreiser, Michael Kallmayer

• Total occlusion of the internal carotid artery – not a benign condition Christos Liapis

• Outcomes following eversion vs. conventional CEA in RCTs and observational studies – a systematic review Kosmas Paraskevas

• Long term outcomes of hybrid revascularization for extracranial symptomatic carotid artery tandem stenosis Armelle Meershoek*

• Early and one year data from the Scaffold (micromesh) CAS Trial Klaus Mathias

• Control of the microembolic burden of the carotid bifurcation lesion: comparison of various endovascular strategies Sumaira MacDonald

• Transcarotid stenting with flow reversal: does the kind of stent matter? Ralf Kolvenbach

• Keynote Lecture: Transcarotid stenting (T-CAR) vs. CEA and transfemoral CAS in the SVS Vascular Quality Initiative Marc Schermerhorn

12.30-12.50 Special Lecture 1 | Lecture Hall B Cognitive impairment and dementia in politicians

Hans Förstl

CAROTID ARTERY DISEASE (CAD) SESSIONS 1–409.00-10.35 CAD 1 | Lecture Hall B

Clinical and imaging variables in asymptomatic carotid patients with an increased late stroke risk – a critical review of the ESVS/ESC guidelines 2017

Chair: Gert de Borst, Holger Poppert

• Clinical variables with an increased late stroke risk Barbara Rantner

• Spontaneous embolisation on TCD and carotid plaque features David Spence

• Silent infarction and impaired cerebrovascular reactivity Peter Ringleb

• Grade of carotid stenosis and stenosis progression Kosmas Paraskevas

• MRI features of unstable carotid plaques Jonathan Nadjiri

• Multi-modal MRI identifies carotid stenosis patients with reduced cerebral blood flow and oxidative metabolism Jens Göttler

• Keynote Lecture: CEA or CAS for asymptomatic carotid stenosis – which patients benefit most? Alison Halliday


* Competing for the MAC Award

THURSDAY

20 21

17.25-18.30 CAD 4 | Lecture Hall C Short communications on Carotid Artery Diseases Chair: Kosmas Paraskevas, Tilman Reiff

• Carotid artery aneurysms – what endovascular treatment can achieve Klaus Mathias

• Gadolinium enhancement and white matter lesions in extracranial carotid artery aneurysms Vanessa Pourier

• The performance of ultrasound particle image velocimetry in a carotid artery phantom with stent Astrid Hoving

• Non-invasive assessment of carotid plaque burden with tomographic ultrasound Christoph Schäffer

• Treatment of internal carotid artery NEar occlusiON (NEON study): an individual patient data meta-analysis Armelle Meershoek

• The choice of the optimal method of surgical correction of atherosclerotic carotid lesions Ihor Kobza

• The ASA classification predicts the ipsilateral stroke free survival in asymptomatic octogenarians with elective CEA Peter Konstantiniuk

• Standardization of semiautomatic tortuosity measurements in the carotid artery Evelien de Vries

• Defining the awake blood pressure in patients undergoing CEA Leonie Fassaert

• Moderate (50%-69%) symptomatic carotis stenosis – what should we do? Pedro Pinto Sousa

• Eligibility to RCTs, do RCTs represent the real world? Michael Kallmayer

CAROTID (CAD) SESSIONS13.30-14.55 CAD 3 | Lecture Hall B

Carotid Stenosis Trialist Collaboration (CSTC) session Chair: Alison Halliday, Claus Zimmer, Leo Bonati

• Stroke and TIA rates at one year in SPACE-2: BMT vs. CEA vs. CAS in asymptomatic carotid stenosis Tilman Reiff

• Current status and perspectives of ACST-2, CREST-2, and ECST-2 Richard Bulbulia

• Safety of CEA and CAS in patients with a history of coronary heart disease in EVA-3S, SPACE, ICSS, and CREST Gert de Borst

• Local anesthesia reduced the 30-day risk of stroke or death after symptomatic CEA – metaanalysis of five RCTs Christoph Knappich

• Risk factors for major operative complications following asymptomatic CEA – 4.440 CEA from VACS, ACAS, ACST-1, and GALA Dylan Morris*

• Carotid stent failure as a predictor for periprocedural stroke or death after CAS – a substudy from ICSS Evelien de Vries*

• Keynote Lecture: Immediate, intermediate, and long-term results after CEA and CAS in four RCTs on symptomatic carotid stenosis Leo Bonati

15.00-15.25 Special Lecture 2 | Lecture Hall B Deadly superbugs from Pharma factories – an investigative report from the NDR Hamburg

Christian Baars

PROGRAMME | THURSDAY, 06 DECEMBER 2018PROGRAMME | THURSDAY, 06 DECEMBER 2018


THURSDAY

22 23


• Intraarterial CEUS – first experience with a new technique to detect early endoleaks in EVAR Matthias Trenner

• Short report: endovascular one stop shopping: EVAR + TAVI Stefan Ockert

• Computer-controlled aortic occlusion (REBOA) for the treatment of cardiac arrest and bleedings Lars Lönn

• Pre- and postoperative factors associated with the persistence of Endoleak Type II after EVAR in the first year of follow up Konstantinos Spanos

• The impact of low profile devices for TEVAR procedures Dittmar Böckler

• Endograft explantation and aortic reconstruction in a patient with AAA rupture following EVAS (video presentation) Piotr Kasprzak

11.00-12.30 AOR 2 | Lecture Hall C Dismantling AAAs – novel insights into disease mechanisms and future therapies

Chair: Lars Maegdefessel, Rebecka Hultgren

• Gender aspects in AAA disease Rebecka Hultgren

• Vascular smooth muscle cell remodelling potentiates abdominal aortic aneurysm growth Marc Bailey

• Multi-modality molecular and cellular imaging to predict AAA growth: towards personalised assessment of disease Rachael Forsythe

• Implementing genetics into clinical practice in cardiovascular disease management Thorsten Kessler

• The association of neutrophil activation markers with morphological features of AAA Wolf Eilenberg*

• Nicotine is a regulator of segmental aortic stiffening – implications for AAA development Markus Wagenhäuser*

• Aorta-on-a-chip: a novel tool to gain molecular insights into aneurysm disease Valentina Paloschi*


AORTIC (AOR) SESSIONS 1–309.00-10.40 AOR 1 | Lecture Hall C Short communications on Aortic Diseases Chair: Rebecka Hultgren, Benedikt Reutersberg, Jaroslav Pelisek

• Different zones (0-2) of hybrid de-branching endovascular aortic repair: outcomes and stroke analysis Ahmed Eleshra

• Mid-term results of hybrid aortic arch repair Mikhail Chernyavskiy

• Acute aortic syndrome – three typical case presentations Pedro Pinto Sousa

• Results of left subclavian artery revascularisation prior to elective TEVAR Arnaud Kerzmann

• Combined TEVAR and EVAR to treat thoracic Type I B endoleak and infrarenal AAA Ahmad Naga

• Late Type I A endoleak after EVAS: a unique challenge Rita Augusto

• Angiogenesis-inhibition and AAA Albert Busch

• Role of neutrophil extracellular traps in AAA disease development and progression Shengliang Liu

• An easily reproducable 3D printed AAA model using open source digital tools Jasamine Coles-Black

• Endovascular aneurysm repair in octogenarians Pedro Pinto Sousa

• Mycotic aortic aneurysm secondary to intravesical BCG instillation – is an endovascular approach effective? Jacinta Campos

• Endovascular diagnostics and treatment of acute abdominal bleedings after upper GI surgery Makhmud Akhmad


THURSDAY

24 25

AORTIC (AOR) SESSIONS13.30-15.00 AOR 3 | Lecture Hall C Biomechanical simulation of aortic aneurysms Chair: Wolfgang Wall, Michael Gee, Markus Kleemann

• Predicting three-dimensional AAA growth from CT-A images Thomas Gasser

• Patient-specific numerical simulation of endovascular aneurysm repair Stephane Avril

• In Silico EVAR for Abdominal Aortic Aneurysms Michael Gee

• Advances in biomechanical and structural AAA wall analysis Tina Cohnert

• Biomechanical modeling of AAA growth and rupture – a clinical perspective Joy Roy

• The SCAN study reveals that cardiovascular patients should be ultrasound-screened for AAA Benedikt Reutersberg

SPECIAL SESSION ON RADIATION PROTECTION15.30-17.00 Special Session 1 | Lecture Hall C Hot topics in radiation protection 2018 Chair: Alexander Oberhuber, Thomas Schmitz-Rixen, Christos Liapis

• Advanced radiation protection in the hybrid OR with Zero Gravity Tina Cohnert

• Practical tips in radiation protection for surgical staff in the hybrid OR Dittmar Böckler

• Mid-term effects of an Intensive radiation-protection-Training on the Intraoperative X-ray-radiation exposure in the hybrid OR Heiko Wendorff

• Radiation exposure during C-arm supported EVAR with the Siemens Pheno system Stefan Ockert

• Risks associated with protracted low dose radiation exposure Bijan Modarai

• Evidence of radiation induced cataracts and brain tumors Dittmar Böckler

• EVAS might be associated with a decrease in intraoperative radiation dose as compared to EVAR Stefan Ockert

PERIPHERAL ARTERIAL DISEASE (PAD) SESSIONS 1–215.40-17.05 PAD 1 | Lecture Hall B

Innovative imaging and below-the-knee treatment modalities Chair: Jonathan Nadjiri, Anders Wanhainen

• DETECT-PAD II: computerized and patient specific model to determine pressure gradients in borderline stenosis with MRA/CTA Jean-Paul de Vries

• Zero contrast procedure by use of unenhanced MRA and CO2 angiography Jos van den Berg

• 3D non-contrast-enhanced ECG-gated MR angiography of the lower extremities Michael Rasper

• The REPEAT study: validation of perfusion angiography measurements for below-the-knee arteries in critcal limb ischaemia Jean-Paul de Vries

• Early results from a RCT on below-the-knee drug-eluting balloons Marianne Brodmann

• Surgical arterialisation of the plantar venous system for foot salvage after failed endovascular or operative revascularisation Achim Neufang

PROGRAMME | THURSDAY, 06 DECEMBER 2018PROGRAMME | THURSDAY, 06 DECEMBER 2018


THURSDAY

26 27

PROGRAMME | THURSDAY, 06 DECEMBER 2018 NOTES

THURSDAY

17.25-18.30 PAD 2 | Lecture Hall B Peripheral and mesenteric vascular emergencies Chair: Achim Neufang, Alexander Zimmermann

• Open or endovascular revascularisation in the treatment of acute lower limb ischaemia Anders Wanhainen

• Outcomes of a consecutive series of 708 patients with acute limb ischaemia – a single center report from Munich Kerstin Stoklasa

• Acute mesenteric ischaemia: irreversible vs. reversible bowel damage – a single center experience Heli Järve*

• Mesenteric vascular injuries in trauma: a National Trauma Data Bank (NTDB) study from the US Shelby Cooper*

• Arterial injury associated with pediatric supracondylar humerus fracture – exploration or observation? Adel Hussein Kamhawy

• Keynote Lecture: Civilian and pediatric vascular trauma management – an overview Ralf Kolvenbach

28 29

• How to detect and to stratify DUS findings at the carotid bifurcation (echolucency, ulceration, etc.) Holger Poppert

• Correlation between plaque characteristics and presence of preoperative white matter lesions in patients undergoing CEA Marjolijn Rots*

• TAXINOMISIS – a multidisciplinary EU project on stratification of patients with carotid artery disease Igor Končar

AORTIC (AOR) SESSIONS 4–708.30-10.05 AOR 4 | Lecture Hall B The new AAA guidelines from the SVS, ESVS, Germany, and UK (NICE) Chair: Julian Scott, Matthias Trenner, Eric Verhoeven

• Keynote Lecture: The new ESVS guidelines – what is new and what is different from the 2017 SVS AAA guidelines? Anders Wanhainen

• Are there any different recommendations in the 2018 AAA guidelines from the German Vascular Society (DGG)? Sebastian Debus

• Changes to the management of patients with AAA in the UK: is NICE out of touch with worldwide best practice? Mike Wyatt

• Some small AAAs (4.5-5.5 cm) should be treated – how to select them? Athanasios Giannoukas

• How valid is the 5/5.5cm diameter threshold for AAA repair and do we need new RCTs to improve the evidence? Thomas Schmitz-Rixen

• Do we need another RCT for AAA 5.0-5.5 or 5.5-6.0 cm? Jes S. Lindholt

• Morphological predictors of an increased AAA rupture risk Igor Končar

• Accuracy of routine endoscopy diagnosing colonic ischaemia after AAA repair – a meta-analysis Clark Zeebregts

CAROTID (CAD) SESSIONS 5–608.30-10.05 CAD 5 | Lecture Hall C Carotid Artery Disease (CAD) – from genes to therapies Chair: Jan Nilsson, Lars Maegdefessel

• Stroke Genetics: discovery, biology, and clinical implications Martin Dichgans

• Targeting SMCs through ncRNA modulation Andrew Baker

• Factors associated with progression of carotid disease in high risk patients Jan Nilsson

• Interplay of oxygen sensors, inflammation, and cholesterol metabolism in atherosclerosis Judith Sluimer

• Morphology and histology of silent and symptom-causing atherosclerotic carotid plaques – the Helsinki CEA Study 2 Pirkka Vikatmaa

• Long non-coding RNA NUDT6 regulates fibrous cap thickness in advanced atherosclerosis Hanna Winter*

• Expression of human somatostatin receptors and glucose transporters in carotid artery stenosis and aneurysms Joachim Schmidt*

10.30-11.40 CAD 6 | Lecture Hall C Carotid plaque burden and vulnerability – assessment and clinical impact

Chair: Eva Bartels, Richard Bulbulia

• Keynote Lecture: Carotid plaque burden predicts future cardiovascular events – why and how I do it! David Spence

• Will carotid plaque volume assessed by 3D tomographic ultrasound be an alternative indicator for CEA or CAS? Steven Rogers

PROGRAMME | FRIDAY, 07 DECEMBER 2018PROGRAMME | FRIDAY, 07 DECEMBER 2018


FRIDAY

30 31

13.00-14.20 AOR 6 | Lecture Hall B Ascending aorta and aortic arch

Chair: Dittmar Böckler, Piotr Kasprzak

• DANCAVAS trial: the incidence of coexisting aortic aneurysms and do we overdiagnose ascending aortic aneurysms? Jes S. Lindholt

• The EACTS/ESVS expert consensus document on thoracic aortic pathologies affecting the aortic arch Martin Czerny

• Status of ascending aortic stent grafts in true aneurysms Ralf Kolvenbach

• Total endovascular treatment of aortic arch pathologies using branched endografts Martin Czerny

• Contact force assessment in the arch during TEVAR: how do different graft designs perform? Celia Riga

• Assessment of flow-displacement and wall-shear-stress by 4D aortic MRA Jonathan Nadjiri

• Repair of acute DeBakey I dissections using a novel dissection – specific arch hybrid graft (AMDS) Ali Shahriari

AORTIC (AOR) SESSIONS 10.30-12.00 AOR 5 | Lecture Hall B Endoleak prevention and management in complex aortic aneurysms Chair: Ralf Kolvenbach, Mike Wyatt

• Qualitative systematic review of studies reporting on re-interventions after elective EVAR Lars Lönn

• Selected Type I and III EL at completion of FEVAR are safe to observe Marc Schermerhorn

• Endovascular strategies for treatment of Type I EL in EVAR Colin Bicknell

• Expansion and atrophy – aortic wall development after EVAR with endoleak Type II Albert Busch

• Determinants of successful and unsuccessful deployment of EndoAnchors in hostile necks – evaluation of >300 implants Jean-Paul de Vries

• Expanding the borders in the treatment of pararenal AAAs with Ch-EVAS Athanasios Giannoukas

• The GLOBAL FACT Registry: a world-wide registry with core lab analysis of fenestrated Anaconda for complex aneurysms Clark Zeebregts

• The (JOTEC®) iliAc BRAnch device for exclusion of Hypogastric Artery aneurysMs – ABRAHAM trial Alexander Oberhuber

12.30-12.45 Special Lecture 3 | Lecture Hall C Sarcopenia and outcomes in vascular surgery Julian Scott



FRIDAY

32 33

PERIPHERAL ARTERIAL DISEASE (PAD) SESSIONS 3–612.45-14.30 PAD 3 | Lecture Hall C

Challenges in PAD – long and calcified lesions, in-stent-restenosis, CLI, and wound healing

Chair: Marianne Brodmann, Heiko Wendorff, Adel Hussein Kamhawy

• Keynote Lecture: Technological advances in the endovascular treatment of calcified peripheral lesions? Thomas Zeller

• Multimodal revascularization strategies in CLI – the Helsinki approach Pirkka Vikatmaa

• 2 year results of the RAPID trial – RCT comparing Legflow DCB with Supera stenting vs. Supera alone for SFA lesions Jean-Paul de Vries

• 2 year results of the COPA CABANA RCT of DCB vs. PTA for femoro-popliteal in-stent restenosis Gunnar Tepe

• Current status of in-stent restenosis treatment in the SFA Jos van den Berg

• EffPac-Trial: Effectiveness of LUMINOR® DCB versus POBA in the SFA Thomas Zeller

• Is stenting of the superficial femoral artery as good as bypass surgery? Data from the Danish Vascular Registry Martin Lawaetz*

• The SVS objective performance goals are achievable for surgical therapy in a consecutive CLI all-comers cohort Alexander Zimmermann

• Closed-incision negative-pressure therapy reduces vascular surgical site infections: the randomized AIMS trial Alexander Gombert*

• Time of complete healing of leg ulcers following revascularisation for critical limb ischaemia George Geroulakos

AORTIC (AOR) SESSIONS14.50-16.40 AOR 7 | Lecture Hall B Thoracic/Thoraco-abdominal aneurysm and dissections Chair: Tina Cohnert, Alexander Zimmermann

• Prevalence of the CTA-based morphological DISSECT predictors in uncomplicated Stanford Type B aortic dissection Dittmar Böckler

• Early TEVAR in acute Type B dissection Igor Končar

• Contemporary treatment of Type B aortic dissection: is there a need for a disease specific approach to endografting? Bijan Modarai

• Treatment of chronic aortic dissections with fenestrated and branched endografts Eric Verhoeven

• Frozen elephant trunk techniques for chronic Type B dissections Celia Riga

• Inner branches as an additional option besides fenestrations and branches in TAAA branched grafting Athanasios Katsargyris

• Prevention and revision of TEVAR utilising EndoAnchors to reduce and treat endoleak Colin Bicknell

• The SPIDERgraft: can this novel technique decrease complications after thoracoabdominal repair? Sebastian Debus

• Side effects of TEVAR and EVAR on the heart – myth or reality? Christos Liapis

• Role of abdominal and thoracic aortic surgery in radical cancer resection Christian Reeps



FRIDAY

34 35

17.00-18.00 PAD 6 | Lecture Hall C Short communications on Peripheral Arterial Disease

Chair: Christoph Knappich, Christian Reeps, Mohamed Ayman Nagib

• Transplantation of stem cells of different origin for the treatment of lower limb ischaemia Dmitry Dombrovsky

• Sarcopenia as predictor of mortality and morbidity following major lower limb amputation Akshitha Kesharaju

• Transbrachial approach as an alternative method in the management of aortoiliac occlusive arterial diseases Mohamed Ayman Nagib

• Acute occlusions of the infrarenal aorta – single-center experience of 68 patients in a 14-year period Sabine Dallmann-Sieber

• Rare atherosclerotic aneurysms of the dorsalis pedis artery in young women – case reports and literature review Bianca Marinelli Teixeira

• Cost-effectiveness of CO2 as contrast medium for the endovascular treatment of PAOD in renal dysfunction Sohiel Nagib

• Adventitial cystic disease of the lower extremity main vessels Yuriy Levchak

PROGRAMME | FRIDAY, 07 DECEMBER 2018

PERIPHERAL ARTERIAL DISEASE (PAD) SESSIONS14.50-15.50 PAD 4 | Lecture Hall C

Update on lipid-lowering therapy in carotid and peripheral atherosclerosis

Chair: Christine Espinola-Klein, Jes S. Lindholt

• Best medical treatment for asymptomatic carotid disease – optimal LDL levels are achievable! David Spence

• Intensive lipid-lowering for plaque stabilisation and regression? Implications for surgeons and our patients! Richard Bulbulia

• Cardiovascular morbidity and mortality in patients with intermittent claudication – medical long-term intervention is a MUST Barbara Rantner

• Survival after lower extremity revascularisation for critical limb-threatening ischaemia (CLTI) is better with high-dose statin Mark Schermerhorn

• PCSK9 inhibitor evolocumab in patients with and without PAD – even better than statins? Thomas Stadlbauer

15.50-16.40 PAD 5 | Lecture Hall C Update on periprocedural and long-term platelet inhibition and anticoagulation in PAD

Chair: Barbara Rantner, Klaus Mathias

• Update on periprocedural and long-term antithrombotic management in PAD Christine Espinola-Klein

• Platelet inhibition PLUS low-dose anticoagulation – a new paradigm for all PAD patients? Thomas Stadlbauer

• How to assess and individualize platelet inhibition in PAD Michael Spannagl

• Cardiovascular outcomes after lower extremity endovascular or surgical revascularization – the EUCLID trial Marianne Brodmann

PROGRAMME | FRIDAY, 07 DECEMBER 2018


FRIDAY

36 37

SPECIAL SESSION ON VASCULAR TEAM TRAINING 17.00-18.05 Special Session 2 | Lecture Hall B Team training, simulation, and augmented reality in the hybrid OR Chair: Colin Bicknell, Albert Busch

• A modular approach for an endovascular training environment using rapid prototyping as part of the Nav-EVAR project Mark Kaschwich*

• Augmented reality for navigated EVAR Markus Kleemann

• Metric-based virtual reality simulation – a paradigm shift in training for severe stroke Thomas Liebig

• An optimised team training for EVAR & TEVAR – how do you set it up and what is the evidence? Celia Riga

• The volume-outcome effect in AAA surgery indicates that trained teams perform better in elective and emergency settings Matthias Trenner

• 3D simulation in the hybrid OR – just a gimmick or a valuable tool? Heiko Wendorff

NOTESPROGRAMME | FRIDAY, 07 DECEMBER 2018

FRIDAY


38 39

• Complications of endovascular treatment of May-Thurner syndrome George Geroulakos

• Technical advances in recanalizing chronic venous obstructions - „skipped Y“ and femoral endophlebectomy Houman Jalaie

11.30-13.00 VEN 3 | Lecture Hall B New developments in lower leg varicose vein disease Chair: Armando Mansilha, Houman Jalaie

• A novel view at the pathogenesis of varicose veins: proteomic analysis Reshaabi Srinanthalogen

• SUPRISE – a RCT on thromboembolic complications in superficial-vein thrombosis under Rivaroxaban or Fondaparinux Jan Beyer-Westendorf

• Interventional treatment of perforator veins Tobias Hirsch

• Is high ligation still an option in superficial-vein thrombosis close to the sapheno-femoral junction? Christian Reeps

• Current status of non-thermal/non-tumescent saphenous ablation Thomas Pröbstle

• LEVEL-2 trial – Endovenous Laser Therapy (EVLT) with long wavelength (1940nm) and reduced energy density Claus-Georg Schmedt

• What do we know about the allergenic risk of adhesive vein treatments? Tobias Hirsch

PROGRAMME | SATURDAY, 08 DECEMBER 2018

VENOUS (VEN) SESSIONS 1–409.00-10.00 VEN 1 | Lecture Hall B Short communications on Venous Diseases Chair: Claus-Georg Schmedt, Rolf Weidenhagen

• Venous stenting: initial experience and follow up in a Portuguese center Luís Gamas

• Laser crossectomy vs. anterior accessory saphenous vein laser ablation for anterior accessory saphenous vein reflux Mohamed Ayman Nagib

• Acute upper extremity deep vein thrombosis (DVT) – indications and effectiveness of superior caval filters Sohiel Nagib

• Role of inferior vena cava filter insertion prior to thrombolysis of acute iliofemoral deep venous thrombosis Mohamed Ismail

• Inferior caval obstruction – limited role of endovenous therapy Mangesh Tarte

• Diagnostic management of the „nutcracker syndrome“ Andrij Nykonenko

• Combined role of laser ablation, ethanol embolisation, and foam sclerotherapy in the treatment of venous malformations Mangesh Tarte

• Surgical management of high- and low-flow vascular malformations Adel Hussein Kamhawy

10.00-11.05 VEN 2 | Lecture Hall B Acute and chronic deep vein thrombosis (DVT) – conservative and recanalizing strategies

Chair: Jan Beyer-Westendorf, Karin Pfister

• Treating acute DVT with DOACs – advances and challenges Armando Mansilha

• Surgical vs. conservative treatment of deep venous thrombosis: follow-up and quality of life Viktor Pavlychenko

• Quality of life and post-thrombotic syndrome after surgical thrombectomy of acute iliofemoral DVT Stefan Ockert


SATURDAY

40 41

NOTES

VENOUS (VEN) SESSIONS13.30-14.45 VEN 4 | Lecture Hall B

The 2015 ESVS guidelines on chronic venous diseases – a critical review

Chair: Thomas Pröbstle, Uta Werthern

• Keynote Lecture: Why the current international guidelines are not always accurate to define the best technique for varicose veins Armando Mansilha

• Multimodal treatment of small saphenous vein reflux Mike Wyatt

• Multimodal treatment of greater saphenous vein reflux Rolf Weidenhagen

• Periprocedural and long-term compression therapy – indications, evidence, and outcomes Karin Pfister

• The postthrombotic syndrome – prevention and recanalizing treatment strategies Houman Jalaie


42 43

MINI-SYMPOSIUM 212.30-13.30 Mini-Symposium 2 | Conference Room 1 The venous challenge – successful strategies to treat venous lesions (Industry Sponsored)

• The endovascular option for AV-fistula creation Tobias Steinke

• How to treat AV-fistula stenosis best Tobias Steinke

• The right way to treat chronic obstructive venous lesions – tips and tricks in diagnostic, indication, and treatment Houman Jalaie

• What did we learn from the „Attract“-Study? Mohammad E. Barbati

MINI-SYMPOSIUM 315.00-16.00 Mini-Symposium 3 | Conference Room 1 Acute Type A dissections: changing paradigms? (Industry Sponsored) Chair: Ali Shahriari, Martin Czerny

MINI-SYMPOSIUM 113.30-14.15 Mini-Symposium 1 | Conference Room 1 Advance Therapy Outcomes in fenestrated and branched EVAR (Industry Sponsored)

• The workflow during complex EVAR – mobile vs. fixed c-arms (with a focus on ARTIS Pheno) Stefan Ockert

• The workflow during FEVAR in the hybrid OR with fusion imaging (syngo EVAR guidance) Eric Verhoeven

• Intraoperative 3D assessment of FEVAR and BEVAR – EVAR guidance and distorsion correction Dittmar Böckler

THURSDAY

MINI-SYMPOSIA | FRIDAY, 07 DECEMBER 2018MINI-SYMPOSIUM | THURSDAY, 06 DECEMBER 2018

FRIDAY

44 45

ACKNOWLEDGEMENTS ACKNOWLEDGEMENTS

€ 15.000 | (rental fee, av services, advertisement)

€ 10.000 | (rental fee, av services, advertisement)

€ 7.500 | (rental fee, av services)








46 47

THURSDAY, 06 DECEMBER 2018SPONSORED / UNSPONSORED WORKSHOPS THURSDAY

No. TOPICS SPONSOR CONVENOR TIME ROOM

WS-1 How to perform in-situ-bypass surgery in critical limb ischaemia (in German)Contents of this workshop:• Indications• How to deal with side branches• How to perform valvulotomy safely

Industry-Sponsored Mario Kuhnert, Birkenwerder, Germany

09.00-11.00 CONFERENCE ROOM 1

WS-2 Meet the expert in cruro-pedal bypass surgery – indications and techniques Contents of this workshop:• How to diagnose a patent distal artery• How to get there easily• Choice of the bypass material• Completion studies

Achim Neufang, Wiesbaden, Germany


WS-3 Meet the expert in CERAB technique for aorto-iliac occlusiv disease (AIOD) – how to get started? Contents of this workshop:• Taylor-made solution• Optimal flow dynamics• Excellent patency

Jean-Paul de Vries,Groningen, The Netherlands


WS-4 Meet the expert in 3D simulation in the hybrid OR (takes place in the hybrid OR)• 3D – necessary or nice to have?• How to implement real 3D-reconstruction of a CT-angiography-scan as

part of the daily routine? • Visit the hybrid OR and use the “state of the art”-Brainlab-software for

vascular surgery

Industry-Sponsored Heiko Wendorff, Munich, Germany

14.30-15.30 meeting point at conference registration counter

THURSDAY

48 49

THURSDAY, 06 DECEMBER 2018SPONSORED / UNSPONSORED WORKSHOPS THURSDAY


WS-5 Meet the expert for interactive planning of arch endografts with scallops and fenestrationsAims of this workshop are:• Morphometric assessment of aortic arch aneurysm• Assessment of potential landing zones• Implantation technique

Industry-Sponsored Alexander Zimmermann, Munich, Germany

15:30-16.30 CONFERENCE ROOM 1

WS-6 Ultrasound of the extracranial carotid bifurcation (plaque characteristics, plaque burden, degree of stenosis, CEUS) Contents of this workshop:• Assessment of carotid plaque characteristics• Measurement of intima-media-thickness and carotid plaque burden

(area and volume)• Assessment of the degree of carotid stenosis• Contrast-enhanced ultrasound (CEUS) of the carotid bifurcation

Thomas Stadlbauer, Munich, GermanyEva Bartels, Munich, Germany


WS-7 Surgical skills cheap and handy! A workshop to improve your vascular skills based on daily shopping Aim: to improve your vascular surgical skills (e.g. suturing, wire navigation) using simple and cheap materials you can acquire during your daily shop-ping in the supermarket and hardware store Type of workshop: practical exercises for personal learning and tutoring for educational training

Albert Busch, Munich, GermanyGabor Biro, Munich, Germany


THURSDAY

50 51

FRIDAY, 07 DECEMBER 2018SPONSORED / UNSPONSORED WORKSHOPS FRIDAY


WS-8 Meet the expert in modern concepts in the therapy of chronic leg wounds Andrea Masset, Munich, Germany


WS-9 Back to the future – take a sutureContents of this workshop:• Suture material• Needles for calcified arteries• Practical tips

Industry-Sponsored Theresia Faber, Hamburg, Germany


WS-10 DAART: Directional atherectomy and antirestenotic therapyContents of this workshop:• Hands on training „Hawk One“ and „Spider FX“ embolic protection device• Indications Hawk One 6 and 7 French• Case examples SFA and BTK

Industry-Sponsored Martina Lopatta, Munich, Germany


WS-11 Intraoperative Duplex Ultrasound (IDUS) – the perfect tool to exclude technical failures after CEAContents of this workshop:• Technical principles of intraoperative duplex ultrasound• Clinical applications• Practical tips and interpretation of intraoperative findings

Industry-Sponsored Christoph Knappich, Munich, Germany Pirkka Vikatmaa, Helsinki, Finland


WS-12 Ultrasound of the abdominal aortaContents of this workshop:• Aortic ultrasound for AAA screening• Technical setting for contrast-enhanced ultrasound (CEUS)

of the infrarenal aorta after EVAR• Detection of Type I and Type II endoleaks

Thomas Stadlbauer, Munich, Germany


FRIDAY

52 53

THURSDAY

KEYNOTE LECTURECEA or CAS for asymptomatic carotid stenosis – which patients benefit most?Alison Halliday, Oxford, UKThursday, 06 December 2018 | 09.00-10.35 | CAD 1 | Lecture Hall B

Alison Halliday is Professor of Vascular Surgery and Honorary Consultant Vascular Surgeon, Oxford University Hospitals. She is Lead Researcher in the ACST Trials and is the recent ESVS President. Her work has contributed to NICE and to the National and International Stroke Guidelines. She has contributed to the ESVS European Guidelines Committee for Extracranial Vascular Disease and is the member of the European Society for Cardio-logy, Council on Stroke.

KEYNOTE LECTURETranscarotid stenting (T-CAR) vs. CEA and transfemoral CAS in the SVS Vascular Quality InitiativeMarc Schermerhorn, Boston, USAThursday, 06 December 2018 | 11.00-12.25 | CAD 2 | Lecture Hall B

Marc Schermerhorn, M.D., is Chief of the Division of Vascular and Endovascular Surgery at Beth Israel Deaconess Medical Center and the George H. A. Clowes Jr. Professor of Surgery at Harvard Medical School. He is Treasurer of the New England Society for Vascular Surgery and a Distinguished Fellow of the Society for Vascular Surgery. He is a member of the European Society for Vascular Surgery, American College of Surgeons, and American Heart Association and serves as a member of the Medical Devices Advi-sory Panel for the FDA and consultant for the Agency for Healthcare Research and Quality. He is a member of three editorial boards and a reviewer for 13 other major journals. In addition, he is an international leader in the field of clinical effectiveness research with a particular focus on the impact of new endovascular therapies on aortic aneurysm repair. He has an NIH funded lab and has authored more than 250 peer-re-viewed articles, case reports, book chapters, and reviews, including original manuscripts in the New England Journal of Medicine, and the Journal of the American Medical Association and has lectured at many national and international forums. He is mentor to numerous surgical residents interested in pursuing careers as clinical investigators.

KEYNOTE/ SPECIAL LECTURES

SPECIAL LECTURE 1Cognitive impairment and dementia in politiciansHans Förstl, Munich, GermanyThursday, 06 December 2018 | 12.30-12.50 | Lecture Hall B

Hans Förstl was born in Munich. He studied medicine and dabbled in various other subjects, all of them less entertaining. After a brief stint in bacteriology he specialized in neurology and then in psychiatry and psychotherapy in Munich, at the Central Institute of Mental Health in Mannheim and the Institute of Psychiatry in London. He was professor of Psychiatry at the University of Western Australia in Perth before he came to sit on the Chair of Psychiatry at the Technische Universität München since 1997. He is still interested in his subject, patients and politics.


54 55

THURSDAY

KEYNOTE LECTUREImmediate, intermediate, and long-term results after CEA and CAS in four RCTs on symptomatic carotid stenosisLeo Bonati, Basle, SwitzerlandThursday, 06 December 2018 | 13.30-14.55 | CAD 3 | Lecture Hall B

Professor Leo Bonati is a Neurologist working in the Department of Neurology at the University Hospital Basel in Switzerland. He is the Head of the Acute Stroke Unit and the Neurovascular Outpatient Clinic of the local Stroke Center. Prof Bonati obtained his MD, Venia Docendi (Habilitation), and Professor of Neurology at the University of Basel. He trained as a clinical Neurologist and clinical researcher in Basel, and spent a two-year Research Fellowship at the University College London’s Institute of Neuro-logy (Queen Square), under the supervision of Prof. Martin M. Brown. Prof Bonati’s main research focus is on carotid artery disease. He led the final analysis of the pivotal International Carotid Stenting Study (ICSS), the largest RCT comparing carotid endarterectomy versus stenting in patients with symptomatic carotid stenosis. A particular focus of Prof Bonati’s research in the field of carotid disease has been the use of magnetic resonance imaging (MRI) for outcome assessment in carotid inter-vention trials. Prof. Bonati is the Coordinator of the Carotid Stenosis Trialists Colla-boration (CSTC), a collaboration between four leading international research groups in the field of carotid disease with the aim of performing pooled analyses of RCT data to select the best treatment for individual patients. He is also a member of the Steering Committee of the 2nd European Carotid Surgery Trial (ECST-2) compa-ring invasive revascularisation versus best medical therapy alone in patients with low-to-intermediate risk carotid disease; neurological Co-Principal Investigator of the 2nd Asymptomatic Carotid Surgery Trial (ACST-2) comparing endarterectomy versus stenting for asymptomatic carotid stenosis; and Principal Investigator of the PRECI-SE-MRI trial comparing ticagrelor versus clopidogrel in patients undergoing carotid artery stenting.Prof Bonati is the Coordinator of the Swiss Stroke Registry, a standardised web-ac-cessible database capturing event-related and follow-up data of all patients with acute cerebrovascular events admitted to certified primary and comprehensive Stro-ke Centers in Switzerland. Further research areas of Prof Bonati include diagnosis and treatment of acute stroke, biomarkers, and atrial fibrillation.


SPECIAL LECTURE 2Deadly superbugs from Pharma factories – an investigative report from the NDR HamburgChristian Baars, Hamburg, GermanyThursday, 06 December 2018 | 15.00-15.25 | Lecture Hall B

Christian Baars works as an editor in the Investigation department of the public broadcaster NDR (ARD) since 2014. He was born in Herdecke (Ruhr area) in 1976. He studied French and political science in Hamburg and Dakar, Senegal. He then worked as an editor for the Tageschau and NDR.de and as a reporter for radio and TV. In 2009 he published a book on Christian fundamentalism. In recent years, he has been intensively working on reports on the spread of multi-resistant bacteria in Germany and India. His research on environmental pollution with antimicrobial agents from pharmaceutical factories has been published as a scientific paper as well (Infection, 2017).

KEYNOTE LECTURECivilian and pediatric vascular trauma management – an overviewRolf Kolvenbach, Düsseldorf, GermanyThursday, 06 December 2018 | 17.25-18.30 | PAD 2 | Lecture Hall B

• Director Department of Vascular Surgery and Endovascular Therapy, Augusta Hospital and Catholic Clinics Group Duesseldorf. Teaching Hospital University of Duesseldorf

• Lecturer and Attending Surgeon Hadassah Medical Centre, University of Jerusalem Israel

• Medical Director Vascular Outpatient Clinic (CAT GmbH) Duesseldorf• Clinical (apl.) Professor of Vascular Surgery, Heinrich – Heine University

of Duesseldorf• Professor Fliedner University Duesseldorf• Honorary Professor Sino-Japanese Friendship Hospital, University of

Beijing, China, Staff Member Department of Cardiovascular Surgery


56 57

KEYNOTE LECTURECarotid plaque burden predicts future cardiovascular events – why and how I do it! David Spence, London, CanadaFriday, 07 December 2018 | 10.30-11.40 | CAD 6 | Lecture Hall C

Professor Spence trained in Neurology and Internal Medicine at Western University in London, Canada, then did a fellowship in Clinical Pharmacology at the Cardiova-scular Research Institute, University of California at San Francisco. He has spent his entire career in stroke prevention. After running a hypertension clinic for 20 years he pioneered measurement of carotid plaque burden for risk stratification, genetic rese-arch, management of patients and evaluation of new therapies for atherosclerosis. His other areas of expertise include B vitamins to lower homocysteine, physiologically individualized therapy for resistant hypertension, transcranial Doppler for risk stratifi-cation in asymptomatic carotid stenosis and patent foramen ovale, and more recently, effects of the intestinal microbiome on atherosclerosis. He has seen over 40,000 pati-ents at high risk of stroke, thereby preventing some 10,000 strokes. However, through his more than 400 publications and more than 600 lectures on stroke prevention to tens of thousands of physicians in 38 countries, he has accomplished much more for stroke prevention than he could achieve as an individual physician.In 2015 he received the Research Excellence Award from the Canadian Society for Atherosclerosis, Thrombosis and Vascular Biology, and in 2017 he was named a Distinguished Alumnus of Western University for Professional Achievement.


KEYNOTE LECTUREThe new ESVS guidelines – what is new and what is different from the 2017 SVS AAA guidelines? Anders Wanhainen, Uppsala, SwedenFriday, 07 December 2018 | 08.30-10.05 | AOR 4 | Lecture Hall B

Anders Wanhainen, MD, PhD, is Professor of Surgery and head of the Vascular Surgical Research Group at Uppsala University, and clinical Chief of the Department of Vascular Surgery, Uppsala University Hospital, Uppsala, Sweden.Professor Wanhainen is a general and vascular surgeon who specializes in advanced open and endovascular surgery of complex aortic aneurysms and dissections. He has served as president of the Swedish Society for Vascular Surgery and council member of the European Society for Vascular Surgery.Professor Wanhainen’s research interests include epidemiological and clinical aspects of aortic diseases, with special focus on pathophysiology, screening, surgi-cal/endovascular repair, and medical treatment. Other areas of interest are vascular infections, carotid disease, extremity ischemia, radiation and abdominal compart-ment syndrome. He has authored more than 200 articles in peer-reviewed medical journals and textbooks, and chaired the new ESVS aortic guideline writing com-mittee. He is the supervisor for 29 PhD-students; eleven who completed their PhD. Professor Wanhainen has been PI for several clinical research projects and receives research grants from the Swedish Research Council and the Swedish Heart and Lung Foundation.He was awarded The Linné Foundation Medical Research Award 2007, The Swedish Surgical Society’s “Great Surgical Research Prize” in 2011, the Swedish Vascular Award 2008 and 2014.Uppsala University, founded in 1477, is the oldest university in Scandinavia. Among the University’s alumni there are 15 Nobel Prize laureates. Uppsala University Hospital has an uptake of approximately 3 million people for highly specialized vas-cular surgery, training and research.


FRIDAY

58 59

KEYNOTE/ SPECIAL LECTURES KEYNOTE/ SPECIAL LECTURES

SPECIAL LECTURE 3Sarcopenia and outcomes in vascular surgeryJulian Scott, Leeds, UKFriday, 07 December 2018 | 12.30-12.45 | Lecture Hall C

Professor Julian Scott graduated medical school in 1981 at Univer-sity of Leicester, UK and was a Houseman to Professor Sir Peter Bell. He undertook basic surgical training in Leicester and Peterborough before taking up a vascular research post looking at lower limb bypass grafts and causes of graft with Professor Michael Horrocks. During his research time he was awarded Patey Prize (SRS), Moyni-han Travelling Fellowship from the ASGBI and a Hunterian Professorship from the RCS England.He was awarded an MD in 1991 from the University of Leicester and completed his higher surgical training in the South West (Bristol and Exeter) and undertook a Senior Vascular Fellowship at the Alfred Hospital in Melbourne. He was appointed a consul-tant Vascular Surgeon in St James Hospital Leeds in 1991. He was the principal investi-gator for the Leeds Aneurysm Development Study and supervised Nine BSc’, 8 MD’s and 11 PhD’s of which six were funded by the BHF. He was made Reader in Vascular Surgery in 2001 and a Hon Professor of Vascular Surgery at the University of Leeds in 2004. He is currently a NHS Consultant Vascular and Trauma Surgery at the Leeds General Infirmary Major Trauma Centre which serves a population of 3 Million. He is a Past President of the Vascular Society of Great Britain and Ireland, Past Chair of the FRCS Vascular and the FEBVS exam Boards and the Current UEMS President of the Section and Board of Vascular Surgery.He was the local PI for CLASS, BASIL 2 and EVRA. He is the current Vascular Lead for the NIHR Medical Innovation centre based in Leeds and a Co-Investigator on a NIHR Global Surgery Grant with interests in surgical innovation in Sierra Leone and India. Professor Scott has edited 1 Book, 5 Book Chapters, 67 Conference Papers and 307 journal articles.

KEYNOTE LECTURETechnological advances in the endovascular treatment of calcified peripheral lesions?Thomas Zeller, Bad Krozingen, GermanyFriday, 07 December 2018 | 12.45-14.30 | PAD 3 | Lecture Hall C

Qualifications09.08.1994 Admission Medical Specialist Internal Medicine10.10.1995 Subarea Term Cardiology12.01.1996 Subarea Term Angiology23.02.2006 Admission “Hypertension Specialist” by the German Hypertension League (DHL)Honors and Awards2001 Young Investigator Award, International College of Angiology 2013 Honorary Membership at the Austrian Society of Angiology2014 Life Time Carreer Achievement Award, C3 congress2015 President elect of the Annual Meeting of the German Society of Angiology2017 Leader In EndoVascular Education (LIVE) Award, VIVA GroupScientific Activity• Member “Guideline Commission” European Society of Cardiology 2012• Current or past: Member of Scientific Committee of „Transcatheter Therapeutics

(TCT) Congress”, Euro-PCR, “Leipzig Interventional Course” (LINC), “Resistant Hypertension Course” (RHC), “Complex Cardiovascular Catheter Therapeutics” (C3); Board of Directors Charing Cross Meeting 2019, Co-Chairman of the Amputation Prevention Meeting (AMP), Complex Cardiovascular Catheter Therapeutics (C3) Meeting, Nationaler Interdisziplinärer Kongress zur kritischen Extremitätenischämie

• Current or in the past: Editorial Board Member of the medical journals VASA, EUROIntervention , Vascular Medicine, Catheterization Cardiovascular Interventions, Journal of Endovascular Therapy, Cardiovascular and Interventional Radiology

• Author of more than 250 peer reviewed original and review articles, editor of the textbook Vascular Medicine – Therapy and Practice

FRIDAY

60 61

KEYNOTE/ SPECIAL LECTURES SAVE THE DATE

KEYNOTE LECTUREWhy the current international guidelines are not always accurate to define the best technique for varicose veinsArmando Mansilha, Porto, PortugalSaturday, 08 December 2018 | 13.30-14.45 | VEN 4 | Lecture Hall B

Certification2001 Specialist in Angiology and Vascular Surgery, Portuguese Medical Association2002 Fellow of the European Board of Vascular Surgery, UEMS2005 PhD in Angiology and Vascular Surgery, Faculty of Medicine of University of Porto

Academic and Hospital appointments (selected)2005 Professor of Angiology and Vascular Surgery, Faculty of Medicine of University of Porto2010 Director, Department of Angiology and Vascular Surgery, Hospital CUF Porto

Positions (selected)2005 Council Member, Union International de Phlébologie2006 Executive Committee, College of Angiology and Vascular Surgery, Portuguese

Medical Association

2008 Secretary General, Portuguese Society of Angiology and Vascular Surgery2009 Secretary General, UEMS Section and Board of Vascular Surgery2009 Council Member, European Society for Vascular Surgery2013 Council Member, Mediterranean League of Angiology and Vascular Surgery2013 Honorary Member, The Vascular Society for Great Britain and Ireland2014 Council Member, International Union of Angiology2015 President of the LOC Annual Meeting, European Society for Vascular Surgery2016 President, European Venous Forum2017 Moynihan Club Member2017 Honorary Member, Societat Catalana d’Angiologia, Cirurgia Vascular I Endovascular2018 President, Portuguese Society of Angiology and Vascular Surgery

SATURDAY

62 63

NOTES NOTES

06–08 December | Klinikum rechts der Isar | Munich | Germany

Chairman Hans-Henning EcksteinMunich, Germany

Venue Klinikum rechts der Isar Munich, Germany

Congress organisationCongO GmbH Ruffinistraße 1680637 Munich, Germany

PROGRAMME - mri.tum.de

Documents

Transcript of PROGRAMME - mri.tum.de